Jörg Kotzerke

10.9k total citations
181 papers, 4.8k citations indexed

About

Jörg Kotzerke is a scholar working on Radiology, Nuclear Medicine and Imaging, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Jörg Kotzerke has authored 181 papers receiving a total of 4.8k indexed citations (citations by other indexed papers that have themselves been cited), including 121 papers in Radiology, Nuclear Medicine and Imaging, 74 papers in Pulmonary and Respiratory Medicine and 30 papers in Oncology. Recurrent topics in Jörg Kotzerke's work include Medical Imaging Techniques and Applications (66 papers), Radiopharmaceutical Chemistry and Applications (59 papers) and Radiomics and Machine Learning in Medical Imaging (29 papers). Jörg Kotzerke is often cited by papers focused on Medical Imaging Techniques and Applications (66 papers), Radiopharmaceutical Chemistry and Applications (59 papers) and Radiomics and Machine Learning in Medical Imaging (29 papers). Jörg Kotzerke collaborates with scholars based in Germany, United States and Italy. Jörg Kotzerke's co-authors include Sven N. Reske, Klaus Zöphel, Bernd Neumaier, Gerhard Glatting, Jörg van den Hoff, Andreas K. Buck, Michaël Baumann, Jörg Steinbach, Holger Schirrmeister and Bettina Beuthien‐Baumann and has published in prestigious journals such as Circulation, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Jörg Kotzerke

176 papers receiving 4.7k citations

Peers

Countries citing papers authored by Jörg Kotzerke

Since Specialization

Citations

This map shows the geographic impact of Jörg Kotzerke's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jörg Kotzerke with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jörg Kotzerke more than expected).

Fields of papers citing papers by Jörg Kotzerke

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jörg Kotzerke. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jörg Kotzerke. The network helps show where Jörg Kotzerke may publish in the future.

Co-authorship network of co-authors of Jörg Kotzerke

This figure shows the co-authorship network connecting the top 25 collaborators of Jörg Kotzerke. A scholar is included among the top collaborators of Jörg Kotzerke based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jörg Kotzerke. Jörg Kotzerke is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Staging metastatic urothelial cancer with Nectin‐4 imaging using Gallium‐68‐ N188 PET / CT 2025 ·British Journal of Urology ·Matthias Miederer, Marc Pretze, (unknown), Andreas Hartig, (unknown), Katharina Böhm, Ulrich Sommer, Sebastian Hoberück, Ralph A. Bundschuh, Jörg Kotzerke, Christian Thomas	2
2	The heterobivalent (SSTR2/albumin) radioligand [⁶⁷Cu]Cu-NODAGA-cLAB4-TATE enables efficient somatostatin receptor radionuclide theranostics 2024 ·Theranostics ·Martin Ullrich, Robert Wodtke, Florian Brandt, Robert Freudenberg, Jörg Kotzerke, Susan Richter, Klaus Kopka, Jens Pietzsch	3
3	Comparison of ZnS(Ag) Scintillator and Proportional Counter Tube for Alpha Detection in Thin-Layer Chromatography 2024 ·Pharmaceuticals ·Marc Pretze, (unknown), Holger Hartmann, Robert Freudenberg, Ralph A. Bundschuh, Jörg Kotzerke, Enrico Michler	1
4	Lead-it-EAZY! GMP-compliant production of [212Pb]Pb-PSC-PEG2-TOC 2024 ·EJNMMI Radiopharmacy and Chemistry ·Marc Pretze, Enrico Michler, (unknown), (unknown), (unknown), Michael K. Schultz, Jörg Kotzerke	4
5	Investigation of Photodynamic Therapy Promoted by Cherenkov Light Activated Photosensitizers—New Aspects and Revelations 2024 ·Pharmaceutics ·(unknown), K. Wetzig, Roswitha Runge, Holger Hartmann, (unknown), (unknown), Marc Pretze, (unknown), Robert Freudenberg, Claudia Brogsitter, Jörg Kotzerke	0
6	Local Control after Locally Ablative, Image-Guided Radiotherapy of Oligometastases Identified by Gallium-68-PSMA-Positron Emission Tomography in Castration-Sensitive Prostate Cancer Patients (OLI-P) 2022 ·Cancers ·Tobias Hölscher, Michaël Baumann, Jörg Kotzerke, Klaus Zöphel, Frank Paulsen, Arndt‐Christian Müller, Daniel Zips, Christian Thomas, Manfred P. Wirth, Esther G.C. Troost, Mechthild Krause, Steffen Löck, Fabian Lohaus	4
7	Molecular Response to Combined Molecular- and External Radiotherapy in Head and Neck Squamous Cell Carcinoma (HNSCC) 2021 ·Cancers ·(unknown), (unknown), Lydia Koi, J. Müller, Robert Freudenberg, Steffen Löck, Wiebke Sihver, (unknown), (unknown), Cläre von Neubeck, Annett Linge, Hans‐Jürgen Pietzsch, Jörg Kotzerke, Michaël Baumann, Mechthild Krause, Antje Dietrich	2
8	Final Results of the Prospective Biomarker Trial PETra: [11C]-MET-Accumulation in Postoperative PET/MRI Predicts Outcome after Radiochemotherapy in Glioblastoma 2020 ·Clinical Cancer Research ·Annekatrin Seidlitz, Bettina Beuthien‐Baumann, Steffen Löck, (unknown), Ivan Platzek, Klaus Zöphel, Annett Linge, Jörg Kotzerke, Jan Petr, Jörg van den Hoff, Jörg Steinbach, Dietmar Krex, (unknown), (unknown), Michaël Baumann, Mechthild Krause	14
9	[68Ga]Ga-PSMA-11 PET before and after initial long-term androgen deprivation in patients with newly diagnosed prostate cancer: a retrospective single-center study 2020 ·EJNMMI Research ·Sebastian Hoberück, Steffen Löck, (unknown), Klaus Zöphel, Michael Froehner, (unknown), Jörg Kotzerke, Tobias Hölscher	15
10	Generation of biological hypotheses by functional imaging links tumor hypoxia to radiation induced tissue inflammation/glucose uptake in head and neck cancer 2020 ·Radiotherapy and Oncology ·Sebastian Zschaeck, Klaus Zöphel, Annekatrin Seidlitz, Daniel Zips, Jörg Kotzerke, Michaël Baumann, Esther G.C. Troost, Steffen Löck, Mechthild Krause	6
11	The prevalence of extramedullary acute myeloid leukemia detected by ¹⁸FDG-PET/CT: final results from the prospective PETAML trial 2019 ·Haematologica ·Friedrich Stölzel, (unknown), Steffen Löck, Stefani Parmentier, (unknown), Michael Krämer, Nael Alakel, Katja Sockel, Franziska Taube, Jan Moritz Middeke, Johannes Schetelig, Christoph Röllig, (unknown), Jörg Kotzerke, Gerhard Ehninger, Martin Bornhäuser, Markus Schaich, (unknown)	34
12	FMISO-PET-based lymph node hypoxia adds to the prognostic value of tumor only hypoxia in HNSCC patients 2018 ·Radiotherapy and Oncology ·Anna Bandurska‐Luque, Steffen Löck, Robert Haase, Christian Richter, Klaus Zöphel, Nasreddin Abolmaali, Annekatrin Seidlitz, Steffen Appold, Mechthild Krause, Jörg Steinbach, Jörg Kotzerke, Daniel Zips, Michaël Baumann, Esther G.C. Troost	15
13	The effect of dimethyl sulfoxide on the induction of DNA strand breaks in plasmid DNA and colony formation of PC Cl3 mammalian cells by alpha-, beta-, and Auger electron emitters 223Ra, 188Re, and 99mTc 2016 ·EJNMMI Research ·Roswitha Runge, Liane Oehme, Jörg Kotzerke, Robert Freudenberg	19
14	Putaminal dopamine turnover in de novo Parkinson disease predicts later motor complications 2015 ·Neurology ·Matthias Löhle, (unknown), Martin Wolz, Bettina Beuthien‐Baumann, Liane Oehme, Jörg van den Hoff, Jörg Kotzerke, Heinz Reichmann, Alexander Storch	26
15	Spatial distribution of FMISO in head and neck squamous cell carcinomas during radio-chemotherapy and its correlation to pattern of failure 2015 ·Acta Oncologica ·Sebastian Zschaeck, Robert Haase, Nasreddin Abolmaali, Rosalind Perrin, Kristin Stützer, Steffen Appold, Jörg Steinbach, Jörg Kotzerke, Daniel Zips, Christian Richter, Volker Gudziol, Mechthild Krause, Klaus Zöphel, Michaël Baumann	48
16	Increased evidence for the prognostic value of primary tumor asphericity in pretherapeutic FDG PET for risk stratification in patients with head and neck cancer 2014 ·European Journal of Nuclear Medicine and Molecular Imaging ·Frank Hofheinz, Alexandr Lougovski, Klaus Zöphel, M. Hentschel, Ingo G. Steffen, Ivayla Apostolova, (unknown), Ralph Buchert, Michaël Baumann, Winfried Brenner, Jörg Kotzerke, Jörg van den Hoff	44
17	Effects of dopaminergic treatment on striatal dopamine turnover in de novo Parkinson disease 2013 ·Neurology ·Alexander Storch, Martin Wolz, Bettina Beuthien‐Baumann, Matthias Löhle, Birgit Herting, Uta Schwanebeck, Liane Oehme, Jörg van den Hoff, (unknown), Xina Grählert, Jörg Kotzerke, Heinz Reichmann	18
18	Prospective Evaluation of Factors Influencing Success Rates of Sentinel Node Biopsy in 814 Breast Cancer Patients 2004 ·Cancer Biotherapy and Radiopharmaceuticals ·Holger Schirrmeister, Jörg Kotzerke, Florian D. Vogl, Andreas K. Buck, Norbert Czech, K Koretz, (unknown), R. Kreienberg, Thorsten Kühn	18
19	[ ¹⁸ F]5-Fluoro-2-Deoxyuridine-PET for Imaging of Malignant Tumors and for Measuring Tissue Proliferation 2003 ·Cancer Biotherapy and Radiopharmaceuticals ·Inga Buchmann, Andreas Vogg, Gerhard Glatting, (unknown), Peter Möller, Frank Leithäuser, M. Schulte, (unknown), Jörg Kotzerke, Sven N. Reske	12
20	Validation of myocardial blood flow estimation with nitrogen-13 ammonia PET by the argon inert gas technique in humans 2001 ·European Journal of Nuclear Medicine and Molecular Imaging ·Jörg Kotzerke, Gerhard Glatting, Jörg van den Hoff, Martin Höher, Bernd Neumaier, Jochen Wöhrle, Sven N. Reske	12

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact